131 filings
Page 4 of 7
8-K
45vekfm1x3kwzjqwh
22 Sep 20
Marinus Announces One-for-Four Reverse Stock Split
9:24am
8-K
2xvhau4
14 Sep 20
Ganaxolone Achieves Primary Endpoint in Phase 3 Trial for CDKL5 Deficiency Disorder (CDD), a Rare Form of Genetic Epilepsy
5:17pm
8-K
929nujh hk5v7p6or6i
14 Sep 20
Marinus Awarded BARDA Contract to Develop IV Ganaxolone for Treatment of Refractory Status Epilepticus Caused by Nerve Agent Exposure
8:05am
8-K
bu51vat
12 Aug 20
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
4:07pm
8-K
ucs6d4x6qcs0yk
30 Jul 20
Marinus Pharmaceuticals Appoints Charles Austin to Board of Directors
12:00am
8-K
y9u8w7
10 Jul 20
Entry into a Material Definitive Agreement
6:02am
8-K
kib8mbxa3
17 Jun 20
Changes in Registrant's Certifying Accountant
5:22pm
8-K
0expw54xbwkp
29 May 20
Entry into a Material Definitive Agreement
4:19pm
8-K
hztuplfc4
27 May 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
3sdiu6isphpr
4 May 20
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
7:45am
8-K
6w0yfw37m5vdq54
2 Apr 20
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
nm5ru
24 Mar 20
Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results
12:00am
8-K
bb2y5q04fus
13 Dec 19
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
4:16pm
8-K
kguzn pd7s
13 Dec 19
Marinus Pharmaceuticals Announces PROPOSED Public Offering of Common Stock AND CONCURRENT PRIVATE PLACEMENT
12:00am
8-K
vu4fb8coh 5sz58v
11 Dec 19
Other Events
12:09pm
8-K
dpmg2j
9 Dec 19
Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting
7:18am
8-K
mzntebpt
8 Nov 19
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter Financial Results
4:03pm
8-K
gxezgiids0idjcp5
29 Oct 19
Marinus Pharmaceuticals Appoints Joe Hulihan, M.D., as Chief Medical Officer
1:31pm
8-K
y6pysw5 af6jlg
21 Oct 19
Regulation FD Disclosure
4:00pm
8-K
2gh o2t9tn4thfj2yt
26 Sep 19
Other Events
12:05pm